Anders Odén1, Martin Fahlén. 1. Valler 190, S-442 92 Romelanda, Sweden. anders.oden@mbox301.swipnet.se
Abstract
OBJECTIVE: To study how mortality varies with different degrees of anticoagulation reflected by the international normalised ratio (INR). DESIGN: Record linkage analysis with death hazard estimated as a continuous function of INR. DATA SOURCES: 46 anticoagulation clinics in Sweden with computerised medical records. SUBJECTS: Records for 42 451 patients, 3533 deaths, and 1.25 million INR measurements. MAIN OUTCOME MEASURES: Mortality from all causes and from intracranial haemorrhage. RESULTS: Mortality from all causes of death was strongly related to level of INR. Minimum risk of death was attained at 2.2 INR for all patients and 2.3 INR for patients with mechanical heart valve prostheses. A high INR was associated with an excess mortality: with an increase of 1 unit of INR above 2.5, the risks of death from cerebral bleeding (149 deaths) and from any cause were about doubled. Among patients with an INR of > or =3.0, 1069 deaths occurred within 7 weeks; if the risk coincided with that with an INR of 2.9, the expected number of deaths would have been 569. Thus at least 500 deaths were associated with a high INR value, but not necessarily caused by the treatment. CONCLUSIONS: The excess mortality associated with high INR values supports the use of less intensive treatment and a small therapeutic window, with INR close to 2.2-2.3 irrespective of the indication for anticoagulant treatment. More preventive actions should be taken to avoid episodes of high INR.
OBJECTIVE: To study how mortality varies with different degrees of anticoagulation reflected by the international normalised ratio (INR). DESIGN: Record linkage analysis with death hazard estimated as a continuous function of INR. DATA SOURCES: 46 anticoagulation clinics in Sweden with computerised medical records. SUBJECTS: Records for 42 451 patients, 3533 deaths, and 1.25 million INR measurements. MAIN OUTCOME MEASURES: Mortality from all causes and from intracranial haemorrhage. RESULTS: Mortality from all causes of death was strongly related to level of INR. Minimum risk of death was attained at 2.2 INR for all patients and 2.3 INR for patients with mechanical heart valve prostheses. A high INR was associated with an excess mortality: with an increase of 1 unit of INR above 2.5, the risks of death from cerebral bleeding (149 deaths) and from any cause were about doubled. Among patients with an INR of > or =3.0, 1069 deaths occurred within 7 weeks; if the risk coincided with that with an INR of 2.9, the expected number of deaths would have been 569. Thus at least 500 deaths were associated with a high INR value, but not necessarily caused by the treatment. CONCLUSIONS: The excess mortality associated with high INR values supports the use of less intensive treatment and a small therapeutic window, with INR close to 2.2-2.3 irrespective of the indication for anticoagulant treatment. More preventive actions should be taken to avoid episodes of high INR.
Authors: M Levine; J Hirsh; M Gent; A Arnold; D Warr; A Falanga; M Samosh; V Bramwell; K I Pritchard; D Stewart Journal: Lancet Date: 1994-04-09 Impact factor: 79.321
Authors: R Altman; J Rouvier; E Gurfinkel; O D'Ortencio; R Manzanel; L de La Fuente; R G Favaloro Journal: J Thorac Cardiovasc Surg Date: 1991-03 Impact factor: 5.209
Authors: Natalie Oake; Alison Jennings; Alan J Forster; Dean Fergusson; Steve Doucette; Carl van Walraven Journal: CMAJ Date: 2008-07-29 Impact factor: 8.262